Skip to content

Prediction of 30-Day Readmission Using Machine Learning

Prediction of 30-Day Readmission Using Machine Learning

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04849312
Enrollment
372
Registered
2021-04-19
Start date
2017-06-01
Completion date
2019-11-30
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anticoagulants; Increased, Asthma, Atrial Fibrillation Rapid, Chronic Kidney Diseases, Chronic Obstructive Pulmonary Disease, Gout Flare, Heart Failure, Hypertensive Urgency, Infection

Brief summary

This is a retrospective observational study drawing on data from the Brigham and Women's Home Hospital database. Sociodemographic and clinic data from a training cohort were used to train a machine learning algorithm to predict the likelihood of 30-day readmission throughout a patient's admission. This algorithm was then validated in a validation cohort.

Interventions

None listed

Sponsors

Brigham and Women's Hospital
Lead SponsorOTHER
Biofourmis Inc.
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Was a subject in the Brigham and Women's Home Hospital study and has a completed record in the study's database.

Design outcomes

Primary

MeasureTime frameDescription
30-Day Readmission [ yes / no ]From date of admission to 30-days post-discharge (31 to 54 days)Unplanned hospital admission within 30 days of having been discharged

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORDavid Levine, MD MPH MA

Associate Physician

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026